Search

Anne L. Holleran

Examiner (ID: 1384, Phone: (571)272-0833 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1643, 1642
Total Applications
775
Issued Applications
297
Pending Applications
125
Abandoned Applications
356

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6372690 [patent_doc_number] => 20100080799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'WSTF REGULATES THE DNA DAMAGE RESPONSE OF H2A.X VIA NOVEL TYROSINE KINASE ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/561573 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 25423 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20100080799.pdf [firstpage_image] =>[orig_patent_app_number] => 12561573 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/561573
WSTF REGULATES THE DNA DAMAGE RESPONSE OF H2A.X VIA NOVEL TYROSINE KINASE ACTIVITY Sep 16, 2009 Abandoned
Array ( [id] => 6355237 [patent_doc_number] => 20100022447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'COMPOSITION FOR TREATING CANCER AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/557507 [patent_app_country] => US [patent_app_date] => 2009-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5813 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022447.pdf [firstpage_image] =>[orig_patent_app_number] => 12557507 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/557507
Composition for treating cancer and use thereof Sep 9, 2009 Issued
Array ( [id] => 6187816 [patent_doc_number] => 20110171216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'MONOCLONAL ANTIBODIES SPECIFIC FOR PANCREATIC NEOPLASIA CELLS' [patent_app_type] => utility [patent_app_number] => 13/062942 [patent_app_country] => US [patent_app_date] => 2009-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 24438 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171216.pdf [firstpage_image] =>[orig_patent_app_number] => 13062942 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/062942
MONOCLONAL ANTIBODIES SPECIFIC FOR PANCREATIC NEOPLASIA CELLS Sep 8, 2009 Abandoned
Array ( [id] => 10018585 [patent_doc_number] => 09061054 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-23 [patent_title] => 'ErbB-2 receptor targeting peptide' [patent_app_type] => utility [patent_app_number] => 12/555375 [patent_app_country] => US [patent_app_date] => 2009-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21888 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12555375 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/555375
ErbB-2 receptor targeting peptide Sep 7, 2009 Issued
Array ( [id] => 9009195 [patent_doc_number] => 08524491 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-03 [patent_title] => 'Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated' [patent_app_type] => utility [patent_app_number] => 12/554279 [patent_app_country] => US [patent_app_date] => 2009-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13296 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12554279 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/554279
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated Sep 3, 2009 Issued
Array ( [id] => 6489051 [patent_doc_number] => 20100009439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'ANTI-IGF-I RECEPTOR ANTIBODIES, DNAs, VECTORS, HOST CELLS AND GENETIC CONSTRUCTS' [patent_app_type] => utility [patent_app_number] => 12/547543 [patent_app_country] => US [patent_app_date] => 2009-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 17363 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20100009439.pdf [firstpage_image] =>[orig_patent_app_number] => 12547543 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/547543
Anti-IGF-I receptor antibodies, DNAs, vectors, host cells and genetic constructs Aug 25, 2009 Issued
Array ( [id] => 7566938 [patent_doc_number] => 20110287001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'METHOD OF TREATMENT' [patent_app_type] => utility [patent_app_number] => 13/063307 [patent_app_country] => US [patent_app_date] => 2009-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10127 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20110287001.pdf [firstpage_image] =>[orig_patent_app_number] => 13063307 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/063307
METHOD OF TREATMENT Aug 4, 2009 Abandoned
Array ( [id] => 9238947 [patent_doc_number] => 08603738 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Metastasis specific splice variants of mena and uses thereof in diagnosis, prognosis and treatment of tumors' [patent_app_type] => utility [patent_app_number] => 12/462324 [patent_app_country] => US [patent_app_date] => 2009-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7578 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12462324 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/462324
Metastasis specific splice variants of mena and uses thereof in diagnosis, prognosis and treatment of tumors Jul 30, 2009 Issued
Array ( [id] => 8397940 [patent_doc_number] => 08268319 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-18 [patent_title] => 'Immunoconjugates with an intracellularly-cleavable linkage' [patent_app_type] => utility [patent_app_number] => 12/512526 [patent_app_country] => US [patent_app_date] => 2009-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11263 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12512526 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/512526
Immunoconjugates with an intracellularly-cleavable linkage Jul 29, 2009 Issued
Array ( [id] => 6348645 [patent_doc_number] => 20100021472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'METHODS FOR DIAGNOSING AND TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 12/510053 [patent_app_country] => US [patent_app_date] => 2009-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 23187 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20100021472.pdf [firstpage_image] =>[orig_patent_app_number] => 12510053 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/510053
METHODS FOR DIAGNOSING AND TREATING CANCER Jul 26, 2009 Abandoned
Array ( [id] => 6374714 [patent_doc_number] => 20100081172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'N-Glycans and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/507047 [patent_app_country] => US [patent_app_date] => 2009-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 30146 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081172.pdf [firstpage_image] =>[orig_patent_app_number] => 12507047 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/507047
N-Glycans and Uses Thereof Jul 20, 2009 Abandoned
Array ( [id] => 5484932 [patent_doc_number] => 20090274697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'Monoclonal Antibodies That Specifically Block Biological Activity Of A Tumor Antigen' [patent_app_type] => utility [patent_app_number] => 12/500144 [patent_app_country] => US [patent_app_date] => 2009-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18967 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20090274697.pdf [firstpage_image] =>[orig_patent_app_number] => 12500144 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/500144
Monoclonal antibodies that specifically block biological activity of a tumor antigen Jul 8, 2009 Issued
Array ( [id] => 5464395 [patent_doc_number] => 20090324595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'CANCER PROGNOSTIC DIAGNOSTIC AND TREATMENT METHODS' [patent_app_type] => utility [patent_app_number] => 12/488296 [patent_app_country] => US [patent_app_date] => 2009-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 29812 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20090324595.pdf [firstpage_image] =>[orig_patent_app_number] => 12488296 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/488296
CANCER PROGNOSTIC DIAGNOSTIC AND TREATMENT METHODS Jun 18, 2009 Abandoned
Array ( [id] => 5373701 [patent_doc_number] => 20090311262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'Method for Diagnosing Cancers Expressing the HER2 Receptor or its Truncated Variants' [patent_app_type] => utility [patent_app_number] => 12/479035 [patent_app_country] => US [patent_app_date] => 2009-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10529 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311262.pdf [firstpage_image] =>[orig_patent_app_number] => 12479035 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/479035
Method for diagnosing cancers expressing the HER2 receptor or its truncated variants Jun 4, 2009 Issued
Array ( [id] => 6588870 [patent_doc_number] => 20100062000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Rhamm, a Co-Receptor and Its Interactions with Other Receptors in Cancer Cell Motility and the Identification of Cancer Prognitor Cell Populations' [patent_app_type] => utility [patent_app_number] => 12/470453 [patent_app_country] => US [patent_app_date] => 2009-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 32919 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20100062000.pdf [firstpage_image] =>[orig_patent_app_number] => 12470453 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/470453
Rhamm, a Co-Receptor and Its Interactions with Other Receptors in Cancer Cell Motility and the Identification of Cancer Prognitor Cell Populations May 20, 2009 Abandoned
Array ( [id] => 6346657 [patent_doc_number] => 20100330554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'DIAGNOSTIC KIT FOR SOLID CANCER AND MEDICAMENT FOR SOLID CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 12/467964 [patent_app_country] => US [patent_app_date] => 2009-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 11169 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330554.pdf [firstpage_image] =>[orig_patent_app_number] => 12467964 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/467964
DIAGNOSTIC KIT FOR SOLID CANCER AND MEDICAMENT FOR SOLID CANCER THERAPY May 17, 2009 Abandoned
Array ( [id] => 5303427 [patent_doc_number] => 20090298079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'HIGH AFFINITY BINDING SITE OF HGFR AND METHODS FOR IDENTIFICATION OF ANTAGONISTS THEREOF' [patent_app_type] => utility [patent_app_number] => 12/465307 [patent_app_country] => US [patent_app_date] => 2009-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9477 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298079.pdf [firstpage_image] =>[orig_patent_app_number] => 12465307 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/465307
High affinity binding site of HGFR and methods for identification of antagonists thereof May 12, 2009 Issued
Array ( [id] => 5969159 [patent_doc_number] => 20110150935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'TARGETED TREATMENT FOR PATIENTS WITH ESTROGEN RECEPTOR NEGATIVE AND PROGESTERONE RECEPTOR NEGATIVE BREAST CANCERS' [patent_app_type] => utility [patent_app_number] => 12/989233 [patent_app_country] => US [patent_app_date] => 2009-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14623 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20110150935.pdf [firstpage_image] =>[orig_patent_app_number] => 12989233 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/989233
Targeted treatment for patients with estrogen receptor negative and progesterone receptor negative breast cancers Apr 21, 2009 Issued
Array ( [id] => 6195542 [patent_doc_number] => 20110027296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'ANTIBODIES FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 12/935838 [patent_app_country] => US [patent_app_date] => 2009-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6586 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027296.pdf [firstpage_image] =>[orig_patent_app_number] => 12935838 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/935838
ANTIBODIES FOR TREATING CANCER Apr 7, 2009 Abandoned
Array ( [id] => 5385155 [patent_doc_number] => 20090226399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'MEDICAMENTS COMPRISING GENE RECOMBINANT ANTIBODY AGAINST GANGLIOSIDE GD3' [patent_app_type] => utility [patent_app_number] => 12/420142 [patent_app_country] => US [patent_app_date] => 2009-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 26884 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226399.pdf [firstpage_image] =>[orig_patent_app_number] => 12420142 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/420142
MEDICAMENTS COMPRISING GENE RECOMBINANT ANTIBODY AGAINST GANGLIOSIDE GD3 Apr 7, 2009 Abandoned
Menu